Black Rock Inc. Amicus Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 22,849,449 shares of FOLD stock, worth $227 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,849,449
Previous 22,988,139
0.6%
Holding current value
$227 Million
Previous $326 Million
17.48%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$280 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$278 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$272 Million3.89% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$187 Million0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY15.7MShares$156 Million0.02% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.78B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...